ArticleAIDS and behavior2026
HIV Prevention Continuum Outcomes Following Implementation of a Municipal HIV Self-Testing Program.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
HIV self-testing (HIVST) must lead to engagement in the HIV status neutral continuum to maximize its benefits. The objective of this research was to determine the reach of a public health HIVST program, characterize the HIV prevention continuum following self-testing, and identify correlates associated with obtaining post-test care and discussing PrEP. We prospectively recruited individuals who obtained an HIVST through a municipal program in Philadelphia, a metropolitan area with high burden of HIV. We examined factors associated with seeing a provider after self-testing, and among those who saw a provider, factors associated with discussing PrEP. Between October 2022 and March 2024, 282 people met inclusion criteria. Men who have sex with men (MSM) comprised 28% of the study sample, 22% identified as Black cis-gender women, and 22% reported no prior HIV test. At one-month follow-up, 53% of respondents with HIV-negative/unknown status saw a provider, but less than a quarter of those discussed PrEP. Black individuals were more than twice as likely to see a provider compared with White individuals. Among those who saw a provider, MSM and Latinx/e individuals were more likely to discuss PrEP, while those assigned female at birth were less likely to discuss PrEP. Implementation of a municipal HIVST program can advance health equity by reaching priority populations, including previously untested persons. Although over half of participants saw a provider after self-testing, very few discussed or initiated PrEP. Interventions to promote linkage to care and PrEP uptake are needed to maximize the impact of HIVST.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.